Search results
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
AbbVie’s RINVOQ now indicated for paediatric arthritis in US
Pharmaceutical Technology via Yahoo Finance· 16 hours agoAbbVie has announced that its RINVOQ (upadacitinib) is now indicated for treating polyarticular...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 13 hours agoImage source: Getty Images. Which high-yielders stand out as attractive buys heading into this event? Healthcare titans AbbVie (NYSE: ABBV) and Pfizer...
ASCO: Replacing chemotherapy with ADCs? AbbVie rebuilds next-gen assets after Rova-T flop
FierceBiotech· 1 day agoA new trend has emerged at this year’s American Society of Clinical Oncology conference: the...
AbbVie Inc. (NYSE:ABBV) Receives $176.14 Average PT from Brokerages
ETF DAILY NEWS· 2 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have earned an average rating of “Moderate Buy” from the fourteen ratings firms that are presently covering the stock, ...
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 2 days agoThe latest trading session saw AbbVie (ABBV) ending at $160.19, denoting a -0.65% adjustment from...
AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) saw its shares surge in the last session with trading volume being higher than...
AbbVie (ABBV) Could Be a Great Choice
Zacks via Yahoo Finance· 2 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...
A company insider recently sold 21,082 shares of Abbvie Inc [ABBV]. Should You Sale? – Knox Daily
Knox Daily· 6 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Abbvie Inc shares valued at $3,716,757 were sold ...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 6 hours agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
